» Articles » PMID: 32653381

Mapping the Underlying Mechanisms of Fibrinogen Benzothiazole Drug Interactions Using Computational and Experimental Approaches

Overview
Publisher Elsevier
Date 2020 Jul 13
PMID 32653381
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional conformational crystallographic binding-modes are of paramount importance to understand the docking mechanism of protein-ligand interactions and to identify potential "leading drugs" conformers towards rational drugs-design. Herein, we present an integrated computational-experimental study tackling the problem of multiple binding modes among the ligand 3-(2-Benzothiazolylthio)-propane sulfonic acid (BTS) and the fibrinogen receptor (E-region). Based on molecular docking simulations, we found that the free energy of binding values for nine of different BTS-docking complexes (i.e., BTS-pose_1-9) were very close. We have also identified a docking-mechanism of BTS-interaction mainly based on non-covalent hydrophobic interactions with H-bond contacts stabilizing the fibrinogen-BTS docking complexes. Interestingly, the different BTS-poses_1-9 were found to be able to block the fibrinogen binding site (E-region) by inducing local perturbations in effector and allosteric residues, reducing the degree of collectivity in its flexibility normal modes. As such, we theoretically suggest that the BTS-binding modes can significantly affect the physiological condition of the unoccupied fibrinogen protein structure by bringing global and local perturbations in the frequency domain spectra. The proposed theoretical mechanisms, the interactions involved and the conformational changes suggested, were further corroborated by different experimental techniques such as isothermal titration calorimetry (ITC), zeta potential, UV-vis, fluorescence and small angle X-ray scattering (SAXS). The combined results shall open new avenues towards the application of complex supra-molecular information in rational drugs-design.

Citing Articles

Identification of fibrinogen as a plasma protein binding partner for lecanemab biosimilar IgG.

Bellier J, Viera A, Christiano C, Anzai J, Moreno S, Campbell E Ann Clin Transl Neurol. 2024; 11(12):3192-3204.

PMID: 39476320 PMC: 11651182. DOI: 10.1002/acn3.52227.


Fluorescence Studies on the Binding Affinity and Determination of Vitamin B12 in the Presence of Fibrinogen.

Gokoglu E, Budun S, Doyuran B, Taskin-Tok T J Fluoresc. 2024; .

PMID: 39007932 DOI: 10.1007/s10895-024-03835-1.


Computational Prediction of the Interaction of Ivermectin with Fibrinogen.

Vottero P, Tavernini S, Santin A, Scheim D, Tuszynski J, Aminpour M Int J Mol Sci. 2023; 24(14).

PMID: 37511206 PMC: 10380762. DOI: 10.3390/ijms241411449.


Biophysical Approaches for the Characterization of Protein-Metabolite Interactions.

Thalhammer A, Broker N Methods Mol Biol. 2022; 2554:199-229.

PMID: 36178628 DOI: 10.1007/978-1-0716-2624-5_13.


Unraveling the Compositional and Molecular Features Involved in Lysozyme-Benzothiazole Derivative Interactions.

Rial R, Gonzalez-Durruthy M, Somoza M, Liu Z, Ruso J Molecules. 2021; 26(19).

PMID: 34641399 PMC: 8510236. DOI: 10.3390/molecules26195855.